Stay updated on TQB2450 Combo vs K Drug in NSCLC Clinical Trial
Sign up to get notified when there's something new on the TQB2450 Combo vs K Drug in NSCLC Clinical Trial page.
Latest updates to the TQB2450 Combo vs K Drug in NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check24 days agoChange DetectedThe website has updated the intervention type to 'Verified 2021-07 by Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Last known status was: Recruiting' and revised to version 2.14.0, while the previous intervention type and version 2.13.3 have been removed.SummaryDifference3%
- Check52 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.3%
- Check60 days agoChange DetectedThe website has been updated from version v2.12.2 to v2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check74 days agoChange DetectedThe website has removed the detailed options for downloading study data, including file formats and specific data fields.SummaryDifference13%
Stay in the know with updates to TQB2450 Combo vs K Drug in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TQB2450 Combo vs K Drug in NSCLC Clinical Trial page.